MRK · Merck & Co., Inc.
127.46
EURUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
Euro313.59B
PE
13.90
EV/EBITDA
9.8
DIV Yield
3.2%
Payout Ratio
45%
MQV Rating
5Very Weak
As at 02/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
Key Fundamentals
EPS 3 yr Growth
18.50%
EBITDA Margin
45.20%
Operating Cashflow
€14,595m
Free Cash Flow Return
17.80%
ROIC
19.70%
Interest Coverage
21.60
Quick Ratio
1.30
Performance
52 weeks range
Low 66.8 - 134.36
Trade Value (12mth)
US$5,725.00
1 week
0.74%
1 month
-1.33%
YTD
43.09%
1 year
89.61%
All time high
134.36
Additional Data
Shares Outstanding (Fully Diluted)
2,470m
HALO Sector
Healthcare
Next Company Report Date
N/A
Next Ex Dividend Date
15-Sep-26
Next Dividend Pay Date
07-Oct-26
Reporting Currency
EUR
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Very Weak
Earnings
Very Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
Key Stakeholders
| Name | Title |
| OrbiMed Advisors Private Equity | Subsidiary |
| Employees Provident Fund | Pension Fund |
| Robert M. Davis | Individual |
| Sanat Chattopadhyay | Individual |
| Richard R. DeLuca | Individual |
